Effect of 17β-oestradiol on fibrinolytic activity and tissue plasminogen activator antigen (t-PA) after nine weeks of treatment
| Placebo (mean (SEM)) | 17β-oestradiol | |||
|---|---|---|---|---|
| 1 mg | 2 mg | |||
| % change from placebo value (95% CI) | ||||
| Fibrinolytic activity (mm2) | 54 (5) | +13 (−13 to +42) | +48 (+13 to +87)2-150 | |
| (p = 0.332) | (p = 0.002) | |||
| t-PA (ng/ml) | 8.3 (1.2) | −18 (−1 to −31) | −31 (−17 to −41) | |
| (p = 0.043) | (p < 0.001) | |||
↵2-150 p < 0.05 v percentage change for 1 mg 17β-oestradiol.